The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Luckily the selling stopped, one sell they all sell for a quick buck buying around 0.75p and selling for 0.8p. I still say 50% from this level is easily achievable just patience needed. What happened to Earl, this was the best thing since sliced bread until he found another stock even better the day after and then another one after that. Makes me chuckle how every day he still pretends to hold everything he pushes
Many old names still about! Good to see an update, share movement shows it’s welcomed.
Carry this on Nige…
Let's hope this manages to stay above 0.08
any upwards movement at the moment is very welcome
0.085p offer and not even 100,000 available online £850 the overhang has been well and truly smashed. 2 premium buys already. I think 50% uplift is fair from here tiny market cap plenty of cash and good news so 1.2p is not unreasonable short term
Good news it's gone NT to buy at 0.8p overhang clearing
Complete bargain
Nice 1.8 mil buy this morning at 0.775p and you can still buy smaller amounts around 0.74p
Somehow Earl if you are not doing a life story on a stock that usually means you are out. No matter what you say if a stock is not going to move you out in a shot. Others with patience will fare better. Added 875k myself 2 x 250k and 375k all around 0.76p while the overhang persists
I’ve joined you both Davey and Earl. My opinion markets not woke up to that RNS this morning. N4P lowest I’ve ever seen it £2m mc unbelievable and news breaks on Nuvec and sirna producing positive effects on cancer tumours.
Davy50
for once I'm going to hold for a while
and I've not sold a bean today.
Earl, problem is you will not see it through I will, already I have matched up a few buys today selling for a loss, was one of them yours. You have to have patience with overhangs but they are great for getting size at all time lows like the buyers are atm below 0.77p
Its been a long time since this many trades have taken place over a single day.
great to see some movement
Https://www.lse.co.uk/rns/holdings-in-company-4guqjrc16mnmcjf.html
After todays Mega rns for the Oncology sector, CEO should be getting calls about the new findings.
JV potential
CEO must be on the phone to his Pharma contacts,
even £10m investment from big Pharma will make this drug delivery system one of the sought after in the world.
Comon Nigel, time to shine
Your welcome Davy50.... my lucky charm.
Seriously £2M Mcap with potential to change the Cancer therapy delivery system industry is going to make N4p holders like myself and like Davy50 very wealthy.
Oh no I've bought a stock with Earl pumping :-))
Anyway all the 0.76-0.77p trades showing as sales are buys and a few are mine.
Strong cash position
£1.2M cash
mcap £2m
Not added any value on the cancer, tumour reduction using its SiRns!!
Don't forget that Tempest Therapeutics gained 3,973% this year on positive news so there is hope for N4P. For those that aren't aware about what happened, Tempest had a similar share price collapse to N4P's which saw it fall to approx $1 US dollar before results from its liver cancer trial were unveiled. Interestingly their MCAP had fallen similarly to N4P's. It then rose from $3 million MCAP to $130 million MCAP....
#n4p
With tiny #mcap £2m
With billions potential make by using it's Tech to reduce #Tumour, improve
#Cancer #therapy treatment
@n4pharma has the world at its feet
Huge rns out
2 RNS in the space of 8 days.
That's wonderful. I sometimes feel like a neglected partner investing in N4P, they ignore us until i'm just about to walk out then they suddenly pay us loads of attention and i'm telling my friends how great they are.
no reason to get overly excited just yet but i'm over the moon the silence is broken.
I hope the team put every effort in getting this RNS seen by as many eyes as possible.
Yes, N4P has a tiny MCAP that could soar on good news. Don't forget that Tempest Therapeutics gained 3,973% this year on positive news so there is hope for N4P. For those that aren't aware about what happened, Tempest had a similar share price collapse to N4P's which saw it fall to approx $1 US dollar before results from its liver cancer trial were unveiled. Interestingly their MCAP had fallen similarly to N4P's. It then rose from $3 million MCAP to $130 million MCAP....
Good luck, Brighty
Good update. Market cap of just over 2 million with its potential is crazy.
Lots of possibilities and maybe, may see a small rise in s.p today, hopefully.
It is abundantly clear from all the data we have been told about over the years that Nuvec has huge potential in reducing the ability for tumour escape. What's also exciting about the RNS today is the fact that Nuvec is successful in ALWAYS loading and delivering dual siRNA. This is obviously good news for N4P's negotiations with big pharma. Come on Nigel lets get a licencing deal with a major company as N4P does not have the resources to go it alone.
Good luck, Brighty